Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX6XGN
|
||||
Drug Name |
6-((3S,6S,9S,14aR)-6-((1H-indol-3-yl)methyl)-9-benzyl-1,4,7,10-tetraoxotetradecahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecin-3-yl)-N-hydroxyhexanamide
|
||||
Synonyms |
CHEMBL1096985
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C33H40N6O6
|
||||
Canonical SMILES |
ONC(=O)CCCCC[C@@H]1NC(=O)[C@H]2CCCN2C(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC1=O
|
||||
InChI |
InChI=1S/C33H40N6O6/c40-29(38-45)16-6-2-5-14-25-30(41)36-26(19-22-20-34-24-13-8-7-12-23(22)24)31(42)37-27(18-21-10-3-1-4-11-21)33(44)39-17-9-15-28(39)32(43)35-25/h1,3-4,7-8,10-13,20,25-28,34,45H,2,5-6,9,14-19H2,(H,35,43)(H,36,41)(H,37,42)(H,38,40)/t25-,26-,27-,28+/m0/s1
|
||||
InChIKey |
OHPVTQHZRUJEEL-LAJGZZDBSA-N
|
||||
Target and Pathway | |||||
Target(s) | Histone deacetylase 6 | Target Info | [1587926] | ||
Histone deacetylase 4 | Target Info | [1587926] | |||
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | Signaling events mediated by HDAC Class II | ||||
Signaling events mediated by HDAC Class Ihdac_classii_pathway:Signaling events mediated by HDAC Class II | |||||
Signaling events mediated by HDAC Class III | |||||
Signaling events mediated by HDAC Class I | |||||
Sumoylation by RanBP2 regulates transcriptional repression | |||||
Validated nuclear estrogen receptor alpha network | |||||
WikiPathways | Ectoderm Differentiation | ||||
Neural Crest Differentiation | |||||
Cell CycleWP474:Endochondral Ossification | |||||
Cardiac Hypertrophic Response | |||||
miR-targeted genes in muscle cell - TarBase | |||||
miR-targeted genes in lymphocytes - TarBase | |||||
miR-targeted genes in epithelium - TarBase | |||||
TarBasePathway | |||||
Cell Cycle | |||||
MicroRNAs in cardiomyocyte hypertrophy | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.